+ A
A -
Tribune News Network
Doha
Qatar Diabetes Association (QDA), member of Qatar Foundation, and Qatar Biomedical Research Institute (QBRI), part of Hamad Bin Khalifa University (HBKU), organised a lecture for parents of children with type 1 diabetes to provide them and the wider community with an in-depth overview of stem cell research.
The lecture was led by QBRI scientists Dr Mohamed Emara, who touched on the subject of the latest advanced research in stem cell technology; and Dr Essam Abdelalim, who discussed diabetes, stem cells therapy and the global research being conducted to improve the treatment of the disease.
Dr Omar El-Agnaf, executive director at QBRI, said: “QBRI’s Diabetes Research Center is fully committed to pursuing novel approaches to tackling diabetes, and especially in light of global forecasts indicating an increase in the number of afflicted patients.
“QDA is a longstanding partner and we share the objective of securing a healthier future for Qatar by raising awareness and enabling the wider community to seek out advice from established experts in the field, as well as showcase QBRI’s advanced knowledge and research efforts in diabetes.”
Members of the audience, including parents of children with type 1 diabetes, were given an opportunity to raise questions to QBRI’s scientists pertaining to the disease and the latest developments in the stem cell research and potential treatment for their family members using this new technology.
Dr Abdulla al Hamaq, executive director of QDA, said: “QDA is committed to running diabetes awareness programmes to promote a greater understanding of diabetes, increase prevention and improve care. We are pleased to collaborate with QBRI in organising this important lecture, which offered the parents an opportunity to gain a clearer understanding of the valuable research led by QBRI. “
He added, “In addition, we are so pleased that parents of children living with diabetes responded to the abundant and valuable scientific information, which confirms that there is important and promising research underway at QBRI.
“We are eagerly keeping an eye on the work of QBRI scientists and their efforts to produce pancreatic cells that secrete insulin in laboratories in efficient and large quantities for future use, to replace infected pancreatic cells.”
Dr Abdelalim said, “The ultimate goal of our stem cell research at QBRI is to pave the way for developing novel therapeutic strategies for diabetes treatment. Our current stem cell projects aim to achieve two main goals, which are understanding genetic factors underlying the development of diabetes using induced pluripotent stem cell technology, and generation of functional insulin-secreting beta cells for cell therapy.”
Dr Emara said, “Using stem cells as a therapeutic tool to treat different diseases is very promising. Currently, there are several clinical trials taking place around the world to test the cure with such new technology. Patients with diabetes, Parkinson’s, Alzheimer’s and other chronic diseases have to know that there is still hope for a complete cure. Stem cell therapy is at the forefront of our efforts and we are looking to conduct research that resonates locally, regionally and globally.”
Doha
Qatar Diabetes Association (QDA), member of Qatar Foundation, and Qatar Biomedical Research Institute (QBRI), part of Hamad Bin Khalifa University (HBKU), organised a lecture for parents of children with type 1 diabetes to provide them and the wider community with an in-depth overview of stem cell research.
The lecture was led by QBRI scientists Dr Mohamed Emara, who touched on the subject of the latest advanced research in stem cell technology; and Dr Essam Abdelalim, who discussed diabetes, stem cells therapy and the global research being conducted to improve the treatment of the disease.
Dr Omar El-Agnaf, executive director at QBRI, said: “QBRI’s Diabetes Research Center is fully committed to pursuing novel approaches to tackling diabetes, and especially in light of global forecasts indicating an increase in the number of afflicted patients.
“QDA is a longstanding partner and we share the objective of securing a healthier future for Qatar by raising awareness and enabling the wider community to seek out advice from established experts in the field, as well as showcase QBRI’s advanced knowledge and research efforts in diabetes.”
Members of the audience, including parents of children with type 1 diabetes, were given an opportunity to raise questions to QBRI’s scientists pertaining to the disease and the latest developments in the stem cell research and potential treatment for their family members using this new technology.
Dr Abdulla al Hamaq, executive director of QDA, said: “QDA is committed to running diabetes awareness programmes to promote a greater understanding of diabetes, increase prevention and improve care. We are pleased to collaborate with QBRI in organising this important lecture, which offered the parents an opportunity to gain a clearer understanding of the valuable research led by QBRI. “
He added, “In addition, we are so pleased that parents of children living with diabetes responded to the abundant and valuable scientific information, which confirms that there is important and promising research underway at QBRI.
“We are eagerly keeping an eye on the work of QBRI scientists and their efforts to produce pancreatic cells that secrete insulin in laboratories in efficient and large quantities for future use, to replace infected pancreatic cells.”
Dr Abdelalim said, “The ultimate goal of our stem cell research at QBRI is to pave the way for developing novel therapeutic strategies for diabetes treatment. Our current stem cell projects aim to achieve two main goals, which are understanding genetic factors underlying the development of diabetes using induced pluripotent stem cell technology, and generation of functional insulin-secreting beta cells for cell therapy.”
Dr Emara said, “Using stem cells as a therapeutic tool to treat different diseases is very promising. Currently, there are several clinical trials taking place around the world to test the cure with such new technology. Patients with diabetes, Parkinson’s, Alzheimer’s and other chronic diseases have to know that there is still hope for a complete cure. Stem cell therapy is at the forefront of our efforts and we are looking to conduct research that resonates locally, regionally and globally.”
